Business
    Next Score View the next score

    Market Movers

    Edwards Lifesciences to buy back shares

    A minimally invasive heart valve from Edwards.
    Associated Press/File 2010
    A minimally invasive heart valve from Edwards.

    Edwards Lifesciences Corp. said that its board has authorized a program to repurchase up to an additional $750 million worth of the company’s stock, Dow Jones reported. The company has a market capitalization value of $7.6 billion, according­ to FactSet. Separately Tuesday, the company said chief financial officer Thomas M. Abate will retire this year; he turns 60 in August. Edwards is the biggest maker of aortic heart valves implanted with a catheter.

    Advertisement